In silico Drug Screening Approach Using L1000-Based Connectivity Map and Its Application to COVID-19
Conventional drug screening methods search for a limited number of small molecules that directly interact with the target protein. This process can be slow, cumbersome and has driven the need for developing new drug screening approaches to counter rapidly emerging diseases such as COVID-19. We propo...
Main Authors: | Takaharu Asano, Sarvesh Chelvanambi, Julius L. Decano, Mary C. Whelan, Elena Aikawa, Masanori Aikawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.842641/full |
Similar Items
-
Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
by: Takeshi Tanaka, et al.
Published: (2022-01-01) -
Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease
by: Julius L. Decano, et al.
Published: (2018-08-01) -
Connections for Matters of the Heart: Network Medicine in Cardiovascular Diseases
by: Abhijeet Rajendra Sonawane, et al.
Published: (2022-05-01) -
Standardization of Human Calcific Aortic Valve Disease in vitro Modeling Reveals Passage-Dependent Calcification
by: Shinji Goto, et al.
Published: (2019-04-01) -
Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS-CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19
by: Prabhash Kumar Jha, et al.
Published: (2021-01-01)